RxDoctor Payments DataLook up a doctor →

Emily Perrotto, APRN

Psychiatric/Mental Health · Mt Juliet, TNNPI 1376134288

Payments from drug & device makers

$9,928in general payments, 2019–2025

Across 554 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Alkermes, Inc.$799
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$555
  • Otsuka America Pharmaceutical, Inc.$519
  • Vanda Pharmaceuticals Inc.$463
  • Neurocrine Biosciences, Inc.$452
  • plus $5K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie161$2,250
Alkermes, Inc.41$799
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)29$555
Otsuka America Pharmaceutical, Inc.29$519
Vanda Pharmaceuticals Inc.24$463
Neurocrine Biosciences, Inc.18$452
Axsome Therapeutics, Inc.25$421
AstraZeneca(2 entities)15$393
Lilly USA, LLC17$323
Pfizer16$319
Biogen15$313
Teva Pharmaceuticals USA, Inc.19$264
Eisai Inc.14$259
TG Therapeutics, Inc.11$251
Lundbeck LLC11$246
EMD Serono, Inc.11$210
SK Life Science, Inc.5$113
Banner Life Sciences, LLC5$101
Biohaven Pharmaceutical Holding Company Ltd.4$100
Corium, LLC4$98
Upsher-smith Laboratories LLC5$80
Avion Pharmaceuticals4$76
CSL Behring4$73
Takeda Pharmaceuticals U.S.A., Inc.5$72
Noven Therapeutics, LLC4$66
Amgen3$66
Neos Therapeutics, LP3$62
Novo Nordisk3$61
Supernus Pharmaceuticals, Inc.4$59
Catalyst Pharmaceuticals, Inc.3$55
Biohaven Pharmaceuticals, Inc.3$54
Avanir Pharmaceuticals, Inc.2$50
Amarin Pharma, Inc.3$49
Acadia Pharmaceuticals Inc2$43
Almatica Pharma LLC2$42
Jazz Pharmaceuticals Inc.2$42
Amneal Pharmaceuticals LLC2$41
UCB, Inc.1$34
Grifols USA, LLC2$33
Argenx US, Inc.1$33
Adlon Therapeutics L.p.2$32
Collegium Pharmaceutical, Inc.2$30
Neurelis, Inc.2$29
E.r. Squibb & Sons, L.L.C.1$27
Currax Pharmaceuticals LLC2$26
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$24
Scilex Pharmaceuticals Inc.1$23
Dexcom, Inc.1$22
Ironshore Pharmaceuticals Inc.1$20
Johnson & Johnson1$20
Idorsia Pharmaceuticals US Inc1$19
GSK1$18
Bausch Health US, LLC1$18
Sage Therapeutics, LLC1$18
Arbor Pharmaceuticals, Inc.1$17
Zealand Pharma US, Inc.1$15
CMP Pharma, Inc.1$15
Merck1$14

How this compares

$9,928 in reported general payments places this provider in the 95th percentile of 1,167 psychiatric/mental health providers in Tennessee.

See all psychiatric/mental health providers in Tennessee →

Medicare billing

Part B allowed, 2024
$29,859
Medicare patients
46
Services billed
417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatric/mental health in Mt Juliet

See the full list for Tennessee →

Where these figures come from

Is this you, or does something look wrong? →